Literature DB >> 21514340

Human and mouse DOCK10 splicing isoforms with alternative first coding exon usage are differentially expressed in T and B lymphocytes.

María José Alcaraz-García1, Natalia Ruiz-Lafuente, Silvia Sebastián-Ruiz, María Juliana Majado, Consuelo González-García, María Victoria Bernardo, María Rocío Alvarez-López, Antonio Parrado.   

Abstract

DOCK10 is a member of the dedicator of cytokinesis (DOCK) family of Rho GTPase activators preferentially expressed in lymphocytes. In this paper, we analyzed DOCK10 mRNA diversity produced because of alternative splicing. Alternative first coding exon usage led to 2 main protein-coding transcripts, DOCK10.1 and DOCK10.2. Full-length cDNA clones of both isoforms were obtained from both normal human peripheral blood mononuclear cells and mouse spleen for the first time for human DOCK10.1, mouse DOCK10.1, and mouse DOCK10.2. Human and mouse DOCK10.1 clones corresponded to the protein coding assemblies provided by the National Center for Biotechnology Information as Reference Sequences for DOCK10. Our analysis especially focused on human cDNA clones, of which 63% were alternatively spliced forms involving diverse exons and introns. DOCK10.1 expression was enriched in normal T cells, and DOCK10.2 expression was enriched in normal B cells and chronic lymphocytic leukemia (CLL) B cells. Both isoforms were upregulated in response to interleukin-4 in B cells, both normal and CLL, but not in T cells. Our data suggest that cell-specific mechanisms regulate expression of the alternative first exon variants of DOCK10 in vertebrates.
Copyright © 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514340     DOI: 10.1016/j.humimm.2011.03.024

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  10 in total

1.  Roles of the DOCK-D family proteins in a mouse model of neuroinflammation.

Authors:  Kazuhiko Namekata; Xiaoli Guo; Atsuko Kimura; Yuriko Azuchi; Yuta Kitamura; Chikako Harada; Takayuki Harada
Journal:  J Biol Chem       Date:  2020-04-02       Impact factor: 5.157

Review 2.  Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn.

Authors:  Nicole M Martinez; Kristen W Lynch
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

3.  Expression of DOCK10.1 protein revealed with a specific antiserum: insights into regulation of first exon isoforms of DOCK10.

Authors:  Antonio Parrado
Journal:  Mol Biol Rep       Date:  2020-02-29       Impact factor: 2.316

4.  Dock10, a Cdc42 and Rac1 GEF, induces loss of elongation, filopodia, and ruffles in cervical cancer epithelial HeLa cells.

Authors:  Natalia Ruiz-Lafuente; María-José Alcaraz-García; Azahara-María García-Serna; Silvia Sebastián-Ruiz; María-Rosa Moya-Quiles; Ana-María García-Alonso; Antonio Parrado
Journal:  Biol Open       Date:  2015-04-10       Impact factor: 2.422

5.  Deletion of Dock10 in B Cells Results in Normal Development but a Mild Deficiency upon In Vivo and In Vitro Stimulations.

Authors:  Natalija Gerasimčik; Minghui He; Marisa A P Baptista; Eva Severinson; Lisa S Westerberg
Journal:  Front Immunol       Date:  2017-05-01       Impact factor: 7.561

6.  DOCK9 induces membrane ruffles and Rac1 activity in cancer HeLa epithelial cells.

Authors:  Natalia Ruiz-Lafuente; Alfredo Minguela; Antonio Parrado
Journal:  Biochem Biophys Rep       Date:  2018-05-22

7.  Expression of DOCK9 and DOCK11 Analyzed with Commercial Antibodies: Focus on Regulation of Mutually Exclusive First Exon Isoforms.

Authors:  Antonio Parrado
Journal:  Antibodies (Basel)       Date:  2020-06-27

8.  Dock10 Regulates Cardiac Function under Neurohormonal Stress.

Authors:  Liad Segal; Sharon Etzion; Sigal Elyagon; Moran Shahar; Hadar Klapper-Goldstein; Aviva Levitas; Michael S Kapiloff; Ruti Parvari; Yoram Etzion
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

9.  Potential role of regulatory DNA variants in modifying the risk of severe cutaneous reactions induced by aromatic anti-seizure medications.

Authors:  Kerry A Mullan; Alison Anderson; Yi-Wu Shi; Jia-Hong Ding; Ching-Ching Ng; Zhibin Chen; Larry Baum; Stacey Cherny; Slave Petrovski; Pak C Sham; Kheng-Seang Lim; Wei-Ping Liao; Patrick Kwan
Journal:  Epilepsia       Date:  2022-02-16       Impact factor: 6.740

10.  The gene expression response of chronic lymphocytic leukemia cells to IL-4 is specific, depends on ZAP-70 status and is differentially affected by an NFκB inhibitor.

Authors:  Natalia Ruiz-Lafuente; María-José Alcaraz-García; Silvia Sebastián-Ruiz; Joaquín Gómez-Espuch; Consuelo Funes; José-María Moraleda; María-Carmen García-Garay; Natividad Montes-Barqueros; Alfredo Minguela; María-Rocío Álvarez-López; Antonio Parrado
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.